Schedule 13G ownership disclosure

NEOS THERAPEUTICS INC

Security class unavailable · CUSIP: 64052L106

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,222,305
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001171520-17-000046
Form type
SC 13G/A
Filer
Iannelli Ralph
CIK
CIK 1648328
Filed
Feb 03, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G/A | SEC Filings Hub